(Reuters) – Exact Sciences Corp said its molecular screening test for colorectal cancer met a late-stage trial goal of detecting the disease in more patients than other commonly used tests, but shares fell 28 percent as the results were not … Continue reading
Commentary: They buy high, sell low, and the ending is predictable.
* FTSE 100 down 1.3 percent, on track for worst week since Nov
Commentary: Social media may help spot the next trend — or bubble.
Pros warn such situations can put the little guy at a big disadvantage.
* Turkey is Europe’s biggest light commercial vehicle maker
Commentary: The next hot IPO? Think bricks, not clicks.
NEW YORK (Reuters) – Hedge fund investors challenging Chesapeake Energy Corp’s plan to redeem $ 1.3 billion of notes without paying a $ 400 million make-whole payment have asked to withdraw from a lawsuit over the matter, allowing a bond … Continue reading
COPENHAGEN (Reuters) – Overweight and obese diabetes patients given high doses of Novo Nordisk’s drug liraglutide achieved 6 percent weight loss in a clinical trial, only slightly above the loss seen in those on a lower dose.